BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32267560)

  • 1. Considerations for Statin Therapy in Patients with COVID-19.
    Dashti-Khavidaki S; Khalili H
    Pharmacotherapy; 2020 May; 40(5):484-486. PubMed ID: 32267560
    [No Abstract]   [Full Text] [Related]  

  • 2. Scientific Rationale for a Bottom-Up Approach to Target the Host Response in Order to Try and Reduce the Numbers Presenting With Adult Respiratory Distress Syndrome Associated With COVID-19. Is There a Role for Statins and COX-2 Inhibitors in the Prevention and Early Treatment of the Disease?
    Verrall GM
    Front Immunol; 2020; 11():2167. PubMed ID: 33013911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy and SAR-COV-2: an available and potential therapy?
    Abdel-Latif RG; Mohammed S; Elgendy IY
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):333-334. PubMed ID: 32379307
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins in coronavirus outbreak: It's time for experimental and clinical studies.
    Bifulco M; Gazzerro P
    Pharmacol Res; 2020 Jun; 156():104803. PubMed ID: 32289478
    [No Abstract]   [Full Text] [Related]  

  • 5. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
    Cadegiani FA
    Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
    [No Abstract]   [Full Text] [Related]  

  • 6. Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
    Ghati N; Roy A; Bhatnagar S; Bhati S; Bhushan S; Mahendran M; Thakur A; Tiwari P; Dwivedi T; Mani K; Gupta R; Mohan A; Garg R; Saxena A; Guleria R; Deepti S
    Trials; 2020 Oct; 21(1):902. PubMed ID: 33126910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
    Dal Moro F; Livi U
    Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
    [No Abstract]   [Full Text] [Related]  

  • 8. The multiple sclerosis (MS) drugs as a potential treatment of ARDS in COVID-19 patients.
    Kloc M; Ghobrial RM
    Mult Scler Relat Disord; 2020 Oct; 45():102437. PubMed ID: 32763844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using "old" medications to fight new COVID-19: Re-purposing with a purpose.
    Wang Y; Foo R; Thum T
    J Mol Cell Cardiol; 2020 Sep; 146():41-42. PubMed ID: 32687852
    [No Abstract]   [Full Text] [Related]  

  • 10. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here?
    Eroğlu I; Çelik Eroğlu B; Uyaroğlu OA; Sain Güven G
    Anatol J Cardiol; 2020 Jul; 24(1):19-20. PubMed ID: 32628145
    [No Abstract]   [Full Text] [Related]  

  • 11. Could ruxolitinib be effective in patients with COVID-19 infection at risk of acute respiratory distress syndrome (ARDS)?
    Caocci G; La Nasa G
    Ann Hematol; 2020 Jul; 99(7):1675-1676. PubMed ID: 32405693
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
    Bendjelid K; Giraud R; Von Düring S
    Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of Effect of Statins in Patients with COVID-19.
    Kow CS; Hasan SS
    Am J Cardiol; 2020 Nov; 134():153-155. PubMed ID: 32891399
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular manifestation and treatment in COVID-19.
    Su YB; Kuo MJ; Lin TY; Chien CS; Yang YP; Chou SJ; Leu HB
    J Chin Med Assoc; 2020 Aug; 83(8):704-709. PubMed ID: 32433342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic therapy in patients with COVID-19 and acute respiratory distress syndrome: Is this a feasible approach?
    Savioli F; Rocha L; Góis A; Nakano LC
    J Trauma Acute Care Surg; 2020 Dec; 89(6):e187-e188. PubMed ID: 32868539
    [No Abstract]   [Full Text] [Related]  

  • 16. Are statins safe in patients with COVID-19?
    Karalis DG
    J Clin Lipidol; 2020; 14(4):396-397. PubMed ID: 32682805
    [No Abstract]   [Full Text] [Related]  

  • 17. Neutrophil Elastase Inhibitors: A potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
    Mohamed MMA; El-Shimy IA; Hadi MA
    Crit Care; 2020 Jun; 24(1):311. PubMed ID: 32513225
    [No Abstract]   [Full Text] [Related]  

  • 18. Erythema multiforme in the context of SARS-Coronavirus-2 infection.
    Sánchez-Velázquez A; Falkenhain D; Rivera Díaz R
    Med Clin (Barc); 2020 Aug; 155(3):141. PubMed ID: 32475615
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 & antiepileptic drugs: Should we pay attention?
    Fırat O; Yalçın N; Demirkan K
    Seizure; 2020 Aug; 80():240-241. PubMed ID: 32663783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.